A. Sidney Barritt IV, MD, MSCR, FAASLD, FACG, is a tenured professor at the University of North Carolina. He is the Director of Hepatology in the UNC liver center and the transplant hepatology fellowship program director. Dr. Barritt conducts clinical outcomes research in metabolic dysfunction associated steatotic liver disease (MASLD), general hepatology, and liver transplantation. Dr. Barritt leads the UNC Liver Center’s clinical trial program in MASLD where he is PI on multiple phase 2 and 3 industry sponsored clinical trials and is also a member of the NIH sponsored Drug Induced Liver Injury Network. Dr. Barritt is also a founding PI for an international registry of patients with liver disease and SARS-CoV-2 infection called SECURE-Liver. Dr. Barritt is a collaborator and advisor to multiple other investigators in the allied schools of health, including the Gillings School of Global Public Health, the Eshelman School of Pharmacy and the UNC Adams School of Dentistry. Outside of work, Dr. Barritt enjoys spending time with his family, road running, and triathlons.